Efficacy of convalescent plasma therapy in immunocompromised patients with COVID-19: A case report

BACKGROUND: Management of immunocompromised COVID-19 patients is the object of current debate. Accumulating evidence suggest that treatment with high-titer COVID-19 convalescent plasma (CCP) may be effective in this characteristic clinical scenario. CASE REPORT: A 52-years old immunocompromised fema...

Descripción completa

Detalles Bibliográficos
Autores principales: Casarola, Genni, D'Abbondanza, Marco, Curcio, Rosa, Alcidi, Riccardo, Campanella, Tommaso, Rossi, Rachele, Fusaro, Jessica, Gandolfo, Vito, Di Giuli, Cinzia, Laoreti, Chiara, Veca, Vito, Leone, Maria Comasia, Pucci, Giacomo, Vaudo, Gaetano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd on behalf of British Infection Association. 2021
Materias:
Case Reports and Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408049/
https://www.ncbi.nlm.nih.gov/pubmed/34490417
http://dx.doi.org/10.1016/j.clinpr.2021.100096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8408049/
https://www.ncbi.nlm.nih.gov/pubmed/34490417
http://dx.doi.org/10.1016/j.clinpr.2021.100096

Ejemplares similares